Multiple carboxylase deficiency due to holocarboxylase synthetase deficiency (Q59572): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(3 intermediate revisions by the same user not shown)
Property / Canary Token
 
dki-india-ID_1184113045
Property / Canary Token: dki-india-ID_1184113045 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 07:05, 14 August 2026

Holocarboxylase synthetase deficiency is a life-threatening early-onset form of multiple carboxylase deficiency (see this term), an inborn error of biotin metabolism, that, if untreated, is characterised by vomiting, tachypnoea, irritability, lethargy, exfoliative dermatitis, and seizures that can worsen to coma.
Language Label Description Also known as
default for all languages
ID_1184113045
    English
    Multiple carboxylase deficiency due to holocarboxylase synthetase deficiency
    Holocarboxylase synthetase deficiency is a life-threatening early-onset form of multiple carboxylase deficiency (see this term), an inborn error of biotin metabolism, that, if untreated, is characterised by vomiting, tachypnoea, irritability, lethargy, exfoliative dermatitis, and seizures that can worsen to coma.

      Statements

      CID11:ID_1184113045
      0 references
      dki-india-ID_1184113045
      0 references
      Concluído
      0 references
      13 August 2026
      0 references